Hillengaß, J., Stoll, J., Zechmann, C., Kunz, C., Wagner, B., Heiß, C., . . . Delorme, S. (2015). The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken. European radiology, 25(3), . https://doi.org/10.1007/s00330-014-3458-5
Chicago-Zitierstil (17. Ausg.)Hillengaß, Jens, et al. "The Application of Gadopentate-Dimeneglumin Has No Impact on Progression Free and Overall Survival as Well as Renal Function in Patients with Monoclonal Plasma Cell Disorders If General Precautions Are Taken." European Radiology 25, no. 3 (2015). https://doi.org/10.1007/s00330-014-3458-5.
MLA-Zitierstil (9. Ausg.)Hillengaß, Jens, et al. "The Application of Gadopentate-Dimeneglumin Has No Impact on Progression Free and Overall Survival as Well as Renal Function in Patients with Monoclonal Plasma Cell Disorders If General Precautions Are Taken." European Radiology, vol. 25, no. 3, 2015, https://doi.org/10.1007/s00330-014-3458-5.